With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Kroger bumped up its annual same-store sales forecast, betting on strong grocery demand to offset reduced discretionary ...

The race to develop muscle-preserving treatments alongside popular obesity drugs like Eli Lillys (NYSE:LLY) Zepbound and Novo ...

The shipments have vaulted Ireland, a country of only five million people, into the second-largest goods-trade imbalance with ...

The U.S.-based Lilly beat rival Novo Nordisk in March this year to introduce its diabetes and weight-loss drug in India ...

A huge surge in Ireland's goods exports in the first quarter of 2025 was partially due to demand for weight loss drugs in the ...

US chemical output slows, National Resilience consolidates operations, AstraZeneca partners with a Chinese firm, and more ...

The first quarter saw the S&P 500 deliver a total return of -4.3%, largely driven by a -5.6% decline in March. Read more here ...

The operations of U.S. businesses account for a big share of Irish economic output, employment and tax revenue. While they have used Ireland as a low-tax base from which to export to the rest of ...

Fresenius recently deconsolidated its Fresenius Medical Care division and now holds a 25% equity stake. As part of this deconsolidation, a significant portion of the company’s debt was also removed ...

DataM Intelligence | competitive Intelligence JAK combos, epigenetic drugs, & non-JAK agents are redefining myelofibrosis treatment offerin ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...